2 Hot Wallstreet Cakes: Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR), Flotek Industries Inc. (NYSE:FTK)

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)

The shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) started off the last trading session with the price of $7.42 while closing the day with the price of $7.54. The shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Rise 1.75% with the Gain of 0.12 points.

The shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) traded with the day volume of 2 Million shares whereas its average trading volume is 1.85 Million.

While analyzing the past performance of the stock we can see that the shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Gain 3.57% in the last week while rising 33.22% in the last month. Past quarter performance shows the green light with 109.44%. The semi-annual and annual performance shows 142.44% and 255.66% respectively.

Some critical values of the shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) to be discussed here are: the beta which shows the value at 2.47 while Average True Range of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) demonstrate the value at 0.47. The weekly and monthly volatility of the shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) are indicated at 5.38% and 8.08%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 73.37.

While studying the financial position of the shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR), we can see that the Market capitalization of the company is at 648.14 Million. The shares outstanding for the company is 85.96 Million and the shares float stands at 79.18 Million. The income of the company stand at -35500000 while the sales stand at 30.6 Million.

Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at -0.48, Price to Earnings or P/E is at 0, Price to Sales P/S show the value of 21.18, the Return on Asset ROA stood at -0.327 and the Return on Equity ROE depicted at -0.422 while Return on Investment ROI is at -0.441.


Flotek Industries Inc. (NYSE:FTK)

Flotek Industries Inc. (NYSE:FTK) started its previous trading session at $6.45 and closed at $6.47 showing a Rise of 0.47 Percent.

The Company traded with an average Volume of 1.09 Million whereas, its Day Volume stood at 833395.

Looking at the performance of the stock, Flotek Industries Inc. (NYSE:FTK) Gain 0.78% in the last week in its shares price and 33.13% in the last month. Quarterly performance shows a green of 43.46 Percent while Semi-Annual and Annual performances shows a 34.79 and -46.04 percent respectively.

Beta for Flotek Industries Inc. (NYSE:FTK) stands at 1.52 while the ATR (average true range) is at 0.33. The Stock’s Weekly and Monthly Volatility is 4.08% and 5.60% respectively showing a RSI value of 62.98.

While studying the financial position of the shares of Flotek Industries Inc. (NYSE:FTK), we can see that the Market capitalization of the company is at 367.82 Million. The shares outstanding for the company is 56.85 Million and the shares float stands at 53.9 Million.

The Company generated an income of -5800000 and the sales of 317.2 Million in the Trailing Twelve Months period.

While analyzing the stock from technical aspects, Diluted Earnings per share stands at $-0.1 a share. P/E (price to earnings) and P/S (price to sales) values are 0 and 1.16 respectively.

The Return on Assets stands at -0.077, ROE shows a value of -0.1 and ROI for Flotek Industries Inc. (NYSE:FTK) is -0.015 as of Trailing Twelve Months period.

View all contributions by

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

    Leave a Comment